D. Miroshnychenko

发表

The impact of tumor stromal architecture on therapy response and clinical progression

Gregory J. Kimmel, Joshua A. Bull, A. Marusyk, 2018, bioRxiv.

Novel role of pleckstrin homology domain of the Bcr-Abl protein: analysis of protein-protein and protein-lipid interactions.

A. Dubrovska, P. Aspenström, D. Miroshnychenko, 2010, Experimental cell research.

Protein-lipid and protein-protein interactions of Bcr PH domain

D. Miroshnychenko, G. Telegeev, S. Maliuta, 2007 .

Spontaneous cell fusions as a mechanism of parasexual recombination in tumour cell populations

A. Tan, M. Bui, D. Basanta, 2021, Nature Ecology & Evolution.

Spontaneous Cell Fusions as a Mechanism of Parasexual Recombination in Tumor Cell Populations

A. Tan, M. Bui, D. Basanta, 2020, bioRxiv.

Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures

Jacob G. Scott, A. Tan, Mingxiang Teng, 2020, Nature Communications.

Paracrine enhancement of tumor cell proliferation provides indirect stroma-mediated chemoresistance via acceleration of tumor recovery between chemotherapy cycles

M. Bui, D. Basanta, A. Marusyk, 2023, bioRxiv.

Harnessing the lymphocyte meta-phenotype to optimize adoptive cell therapy

Jacob G. Scott, Fadoua El Moustaid, A. Marusyk, 2016, bioRxiv.

Paracrine enhancement of tumor cell proliferation provides indirect stroma-mediated chemoresistance via acceleration of tumor recovery between chemotherapy cycles

M. Bui, D. Basanta, A. Marusyk, 2023, bioRxiv.

Dissecting the Spatially Restricted Effects of Microenvironment-Mediated Resistance on Targeted Therapy Responses

D. Basanta, A. Marusyk, D. Miroshnychenko, 2024, Cancers.

Peristromal niches protect lung cancers from targeted therapies through a combined effect of multiple molecular mediators

Chandler D. Gatenbee, Sandhya Prabhakaran, D. Basanta, 2024, bioRxiv.